Terms ending in 2036
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,202,354 | Therapeutic Compounds and Uses Thereof In force · Medium confidence | Constellation Pharmaceuticals, Inc. | In force | Medium confidence | |
| US 10,239,861 | Therapeutic Compounds and Uses Thereof In force · Medium confidence | Constellation Pharmaceuticals, Inc. | In force | Medium confidence | |
| US 10,280,149 | Therapeutic Compounds and Uses Thereof In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,912,823 | Methods of Preparing a Poloxamer for Use in Cell Culture Medium In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,202,378 | Therapeutic Compounds and Uses Thereof In force · High confidence | Constellation Pharmaceuticals, Inc. | In force | High confidence | |
| US 12,098,426 | Gene Expression Markers and Treatment of Multiple Sclerosis In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 10,330,683 | Mutant Smoothened and Methods of Using the Same In force · High confidence | Université Paris Cité | In force | High confidence | |
| US 11,236,391 | Gene Expression Markers and Treatment of Multiple Sclerosis In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,077,318 | Cysteine Engineered Antibodies and Conjugates In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,179,782 | Substituted Sulfonamide Compounds In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| 101 more term ends in 2036 · Pro | |||||
10 of 111 patents shown. Soonest term end first, then patent number.
Pro members see all 111.
101 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.